We also show that SETD2 mutations, which occur frequently in renal cell carcinomas, render these cancer cells resistant to ferroptosis, thereby uncovering a pro-oncogenic mechanism dependent on intracellular iron regulation. This evidence concerns the gene SETD2 and cancer.